Natera Inc
NASDAQ:NTRA

Watchlist Manager
Natera Inc Logo
Natera Inc
NASDAQ:NTRA
Watchlist
Price: 143.94 USD -2.94% Market Closed
Market Cap: 19.5B USD

P/FCFE
Price to FCFE

376.3
Current
-14
Median
25.4
Industry
Higher than median
Higher than industry value

Price to Free Cash Flow To Equity (P/FCFE) ratio is a valuation multiple that compares a company’s market capitalization to the amount of free cash flow available for equity shareholders. This metric is very similar to the P/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

P/FCFE
376.3
=
Market Cap
19.1B USD
/
FCFE
50.7m USD
Market Cap P/FCFE
US
Natera Inc
NASDAQ:NTRA
19.1B USD 376.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -3 113 067.9
US
Abbvie Inc
NYSE:ABBV
362.4B USD 16.5
US
Amgen Inc
NASDAQ:AMGN
164.8B USD 51.4
US
Gilead Sciences Inc
NASDAQ:GILD
139.3B USD 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD -133.8
US
Epizyme Inc
F:EPE
94.1B EUR -440.8
AU
CSL Ltd
ASX:CSL
122.4B AUD 54.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
69.9B USD 20
US
Seagen Inc
F:SGT
39.3B EUR -60.6
NL
argenx SE
XBRU:ARGX
33B EUR -107

P/FCFE Forward Multiples

Forward P/FCFE multiple is a version of the P/FCFE ratio that uses forecasted free cash flow to equity for the P/FCFE calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to equity forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/FCFE
N/A
2-Years Forward
P/FCFE
N/A
3-Years Forward
P/FCFE
N/A